Abstract
Ghrelin regulates bone formation and osteoblast proliferation, but the detailed signaling pathway for its action on osteoblasts remains unclear. In human osteoblastic TE85 cells, we observed the effects and intracellular signaling pathway of ghrelin on cell proliferation using BrdU incorporation method. Ghrelin, at 10−10–10−8 M concentration, significantly increased BrdU incorporation into TE85 cells. The action of ghrelin was inhibited by d-Lys3-GHRP-6, a selective antagonist of GHS-R. Nitric oxide (NO) scavenger hemoglobin and the NO synthase inhibitor NAME eliminated the stimulatory action of ghrelin on proliferation, while NO donor SNAP and NO synthase substrate L-AME stimulated proliferation of osteoblastic TE85 cells. The cGMP analogue, 8-Br-cGMP, stimulated TE85 cell proliferation, and ghrelin did not enhance proliferation in the presence of 8-Br-cGMP. Inhibition of cGMP production by the guanylate cyclase inhibitor prevented ghrelin-induced osteoblastic TE85 cell proliferation. In conclusion, ghrelin stimulates proliferation of human osteoblastic TE85 cells via intracellular NO/cGMP signaling pathway.
Similar content being viewed by others
References
M. Kojima, H. Hosoda, Y. Date et al., Nature 402(6762), 656 (1999)
Y. Date, M. Kojima, H. Hosoda et al., Endocrinology 141(11), 4255 (2000)
M. Tschop, D.L. Smiley, M.L. Heiman, Nature 407(6806), 908 (2000)
A. Torsello, E. Bresciani, G. Rossoni et al., Endocrinology 144(5), 1787 (2003)
F. Broglio, C. Gottero, E. Arvat et al., Horm. Res. 59(3), 109 (2003)
I. Pettersson, G. Muccioli, R. Granata et al., J. Endocrinol. 175(1), 201 (2002)
M.S. Kim, C.Y. Yoon, P.G. Jang et al., Mol. Endocrinol. 18(9), 2291 (2004)
Y.J. Park, Y.J. Lee, S.H. Kim et al., Mol. Cell. Endocrinol. 285(1–2), 19 (2008)
N. Fukushima, R. Hanada, H. Teranishi et al., J. Bone Miner. Res. 20(5), 790 (2005)
T. Wells, P.A. Houston, J. Neuroendocrinol. 13(6), 496 (2001)
J. Svensson, S. Lall, S.L. Dickson et al., J. Endocrinol. 165(3), 569 (2000)
S.W. Kim, S.J. Her, S.J. Park et al., Bone 37(3), 359 (2005)
A.D. Howard, S.D. Feighner, D.F. Cully et al., Science 273(5277), 974 (1996)
M.M. Malagon, R.M. Luque, E. Ruiz-Guerrero et al., Endocrinology 144(12), 5372 (2003)
M. Yamazaki, H. Kobayashi, T. Tanaka et al., J. Neuroendocrinol. 16(10), 825 (2004)
F. Rodriguez-Pacheco, R.M. Luque, M. Tena-Sempere et al., J. Neuroendocrinol. 20(3), 406 (2008)
X.F. Han, Y.L. Zhu, M. Hernandez et al., Endocrine 28(2), 217 (2005)
M.S. Duxbury, T. Waseem, H. Ito et al., Biochem. Biophys. Res. Commun. 309(2), 464 (2003)
P.L. Jeffery, A.C. Herington, L.K. Chopin, J. Endocrinol. 172(3), R7 (2002)
M. Murata, Y. Okimura, K. Iida et al., J. Biol. Chem. 277(7), 5667 (2002)
P. Cassoni, M. Papotti, C. Ghe et al., J. Clin. Endocrinol. Metab. 86(4), 1738 (2001)
C. Ghe, P. Cassoni, F. Catapano et al., Endocrinology 143(2), 484 (2002)
M. Volante, E. Allia, E. Fulcheri et al., Am. J. Pathol. 162(2), 645 (2003)
G. Maccarinelli, V. Sibilia, A. Torsello et al., J. Endocrinol. 184(1), 249 (2005)
K.K. McKee, O.C. Palyha, S.D. Feighner et al., Mol. Endocrinol. 11(4), 415 (1997)
J. Torreilles, Front Biosci. 6, D1161 (2001)
Y. Kanamaru, T. Takada, R. Saura et al., Kobe J. Med. Sci. 47(1), 1 (2001)
I.C. Lin, J.M. Smartt Jr., H.D. Nah et al., Plast. Reconstr. Surg. 121(5), 1554 (2008)
M.C. O’Shaughnessy, J.M. Polak, F. Afzal et al., Biochem. Biophys. Res. Commun. 277(3), 604 (2000)
P. Diniz, K. Soejima, G. Ito, Nitric Oxide 7(1), 18 (2002)
C.C. Chang, Y.S. Liao, Y.L. Lin et al., J. Orthop. Res. 24(10), 1917 (2006)
B. Roy, J. Garthwaite, Proc. Natl. Acad. Sci. USA 103(32), 12185 (2006)
L. Mancini, N. Moradi-Bidhendi, L. Becherini et al., Biochem. Biophys. Res. Commun. 274(2), 477 (2000)
H. Hagiwara, A. Inoue, A. Yamaguchi et al., Am. J. Physiol. 270(5 Pt 1), C1311 (1996)
Z. Li, G. Zhang, R. Feil et al., Blood 107(3), 965 (2006)
T.L. Horvath, S. Diano, P. Sotonyi et al., Endocrinology 142(10), 4163 (2001)
M.L. Heiman, D.R. Witcher, Metab. Syndr. Relat. Disord. 4(1), 37 (2006)
R.C. Olney, Med. Pediatr. Oncol. 41(3), 228 (2003)
Y. Kasukawa, N. Miyakoshi, S. Mohan, Curr. Pharm. Des. 10(21), 2577 (2004)
Acknowledgement
This work is supported by the National Natural Science Foundation of China (No. 30300413 and No. 30471738).
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors Deng-Hu Wang and Yun-Sheng Hu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wang, DH., Hu, YS., Du, JJ. et al. Ghrelin stimulates proliferation of human osteoblastic TE85 cells via NO/cGMP signaling pathway. Endocr 35, 112–117 (2009). https://doi.org/10.1007/s12020-008-9117-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-008-9117-3